Re: Farmas USA
y DVAX combatiendo esos 2,05 que tiene que sobrepasar pero ya!!!
y DVAX combatiendo esos 2,05 que tiene que sobrepasar pero ya!!!
ARNA
http://invest.arenapharm.com/secfiling.cfm?filingid=1193125-14-8858&CIK=1080709
filing 8k
repaso a todo lo que tienen en marcha
3.30 + 10.%
Dendreon Announces Preliminary Fourth Quarter 2013 Revenues
SEATTLE --(BUSINESS WIRE)-- Dendreon Corporation (NASDAQ: DNDN) today announced preliminary revenues for the fourth quarter ended December 31, 2013 . Net product revenue for the quarter is expected to be approximately $74.8 million , up 10.1% on a sequential basis.
Recent Highlights:
Business has continued to strengthen
Community oncology grew 19% overall quarter over quarter Community urology grew 2% overall quarter over quarter Community accounts represent 72% of total sales Academic grew 5% quarter over quarter Continued large account growth
100 large accounts in Q4, up from 94 in Q3, 85 in Q2 and 54 in Q1 Continued to generate new physician interest in PROVENGE® (sipuleucel-T)
Added 31 net new accounts in Q4 Continued progress on restructuring and cost reduction plan to accelerate the path to profitability; continue to expect net benefits to begin to be realized as early as Q1 2014 Advancing automation efforts
Recently conducted a constructive meeting with the FDA regarding automation of the PROVENGE manufacturing process; Agency expressed its support for this effort Cash on hand of approximately $199 million as of December 31, 2013 Continue to develop clinical data in the active cellular immunotherapy space Plans to present data from ongoing immuno-oncology trials, which further elucidate the product potency and mechanism of PROVENGE, and surrounding investigational compound DN24-02, at ASCO-GU later this month
juas, me ha durado horas ticket de AMRN.
Luego la vuelvo a mirar.
RNN .. sigue su marcha imparable.
No me gusta que queden espacios sin llenar "gap".
DVAX
MACK
El 15 (miercoles) participa en la conferencia JPM14 y el 16 (jueves) libera datos del MM-111 en el ASCO GI de San Francisco.
http://investors.merrimackpharma.com/releasedetail.cfm?ReleaseID=818827
ROSG
Otra deshauciada que despierta. +34%
BAXS
Se veia venir, y yo fuera :-(
CVM
Hoy parece que da entrada. El miedo es el poco cash.
Por mi que lo rellene en esos 1,95 si quiere
Lo que me gustan son los 3,06 millones de acciones compradas el Viernes a 1,93-1,94
yo llevo stop profit ya puesto en 1,90.
DVAX